The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

mbrdr: Model-Based Response Dimension Reduction

Functions for model-based response dimension reduction. Usual dimension reduction methods in multivariate regression focus on the reduction of predictors, not responses. The response dimension reduction is theoretically founded in Yoo and Cook (2008) <doi:10.1016/j.csda.2008.07.029>. Later, three model-based response dimension reduction approaches are proposed in Yoo (2016) <doi:10.1080/02331888.2017.1410152> and Yoo (2019) <doi:10.1016/j.jkss.2019.02.001>. The method by Yoo and Cook (2008) is based on non-parametric ordinary least squares, but the model-based approaches are done through maximum likelihood estimation. For two model-based response dimension reduction methods called principal fitted response reduction and unstructured principal fitted response reduction, chi-squared tests are provided for determining the dimension of the response subspace.

Version: 1.1.1
Depends: R (≥ 3.5.0)
Imports: stats
Published: 2022-01-24
DOI: 10.32614/CRAN.package.mbrdr
Author: Jae Keun Yoo
Maintainer: Jae Keun Yoo <peter.yoo at ewha.ac.kr>
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2.0)]
NeedsCompilation: no
CRAN checks: mbrdr results

Documentation:

Reference manual: mbrdr.pdf

Downloads:

Package source: mbrdr_1.1.1.tar.gz
Windows binaries: r-devel: mbrdr_1.1.1.zip, r-release: mbrdr_1.1.1.zip, r-oldrel: mbrdr_1.1.1.zip
macOS binaries: r-release (arm64): mbrdr_1.1.1.tgz, r-oldrel (arm64): mbrdr_1.1.1.tgz, r-release (x86_64): mbrdr_1.1.1.tgz, r-oldrel (x86_64): mbrdr_1.1.1.tgz
Old sources: mbrdr archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=mbrdr to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.